SECONDARY CYTOREDUCTIVE SURGERY IN OVARIAN-CANCER

被引：0
|
作者：
JANICKE, F
SCHATTENMANN, G
KUHN, W
GRAEFF, H
SIEWERT, JR
机构：
[1] TECH UNIV MUNICH, FRAUENKLIN & POLIKLIN, MUNICH, GERMANY
[2] TECH UNIV MUNICH, CHIRURG KLIN & POLIKLIN, MUNICH, GERMANY
来源：
CHIRURG | 1994年 / 65卷 / 01期
关键词：
RECURRENT OVARIAN CANCER; SECONDARY CYTOREDUCTIVE SURGERY; 2ND-LINE CHEMOTHERAPY; PROGNOSTIC PARAMETERS;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：10 / 17
页数：8
相关论文
共 50 条
  • [31] Recurrent micropapillary serous ovarian carcinoma - The role of secondary cytoreductive surgery
    Bristow, RE
    Gossett, DR
    Shook, DR
    Zahurak, ML
    Tomacruz, RS
    Armstrong, DK
    Montz, FJ
    CANCER, 2002, 95 (04) : 791 - 800
  • [32] Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer - Analysis of prognostic factors and survival outcome
    Salani, Ritu
    Santillan, Antonio
    Zahurak, Marianna L.
    Giuntoli, Robert L., II
    Gardner, Ginger J.
    Armstrong, Deborah K.
    Bristow, Robert E.
    CANCER, 2007, 109 (04) : 685 - 691
  • [33] Do all patients that undergo a 'complete' secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
    Bhatt, Aditi
    Mehta, Sanket
    Glehen, Olivier
    PLEURA AND PERITONEUM, 2024, 9 (03) : 93 - 105
  • [34] Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
    Soo Young Jeong
    Chel Hun Choi
    Tae Joong Kim
    Jeong Won Lee
    Byoung-Gie Kim
    Duk Soo Bae
    Yoo-Young Lee
    Journal of Ovarian Research, 13
  • [35] Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
    Jeong, Soo Young
    Choi, Chel Hun
    Kim, Tae Joong
    Lee, Jeong Won
    Kim, Byoung-Gie
    Bae, Duk Soo
    Lee, Yoo-Young
    JOURNAL OF OVARIAN RESEARCH, 2019, 13 (01)
  • [36] Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis
    Petrillo, M.
    Anchora, L. Pedone
    Tortorella, L.
    Fanfani, F.
    Gallotta, V.
    Pacciani, M.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 257 - 261
  • [37] Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial
    Praiss, Aaron M.
    Zhou, Qin
    Iasonos, Alexia
    Moukarzel, Lea
    Dessources, Kimberly
    Soldan, Krysten
    Su, Katy
    Sonoda, Yukio
    Roche, Kara Long
    Gardner, Ginger J.
    Troso-Sandoval, Tiffany
    Tew, William P.
    Grisham, Rachel N.
    Chi, Dennis S.
    O'Cearbhaill, Roisin E.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2023, 171 : 23 - 30
  • [38] Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer
    Felsinger, Michal
    Minar, Lubos
    Weinberger, Vit
    Rovny, Ivo
    Zlamal, Filip
    Bienertova-Vasku, Julie
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 228 : 154 - 160
  • [39] Secondary cytoreductive surgery outcomes of selected patients with paclitaxel/platinum sensitive recurrent epithelial ovarian cancer
    Boran, Nurettin
    Hizli, Deniz
    Yilmaz, Saynur
    Turan, Taner
    Celik, Bulent
    Karabuk, Emine
    Isikdogan, Zuhal
    Tulunay, Gokhan
    Kose, M. Faruk
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (04) : 369 - 375
  • [40] Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer
    Tentes, Antonios-Apostolos K.
    Korakianitis, Odysseas S.
    Kakolyris, Stylianos
    Kyziridis, Dimitrios
    Veliovits, Dousan
    Karagiozoglou, Chrysa
    Sgouridou, Evanthia
    Moustakas, Konstantinos
    TUMORI, 2010, 96 (03) : 411 - 416
12345